Raymond James Financial Services Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,072
| Closed | -$4.69K | – | 3584 |
|
|
2024
Q2 | $4.69K | Buy |
14,072
+39
| +0.3% | +$11 | ﹤0.01% | 3389 |
|
|
2024
Q1 | $3.23K | Sell |
14,033
-110
| -0.8% | -$32 | ﹤0.01% | 3381 |
|
|
2023
Q4 | $4.51K | Buy |
14,143
+110
| +0.8% | +$28 | ﹤0.01% | 3278 |
|
|
2023
Q3 | $3.79K | Hold |
14,033
| – | – | ﹤0.01% | 3253 |
|
|
2023
Q2 | $7.09K | Hold |
14,033
| – | – | ﹤0.01% | 3216 |
|
|
2023
Q1 | $9.23K | Buy |
14,033
+1,500
| +12% | +$1.02K | ﹤0.01% | 3228 |
|
|
2022
Q4 | $4.35K | Sell |
12,533
-3,765
| -23% | -$1.53K | ﹤0.01% | 3224 |
|
|
2022
Q3 | $7K | Sell |
16,298
-1,996
| -11% | -$1.04K | ﹤0.01% | 3226 |
|
|
2022
Q2 | $7K | Sell |
18,294
-1,562
| -8% | -$697 | ﹤0.01% | 3221 |
|
|
2022
Q1 | $12K | Sell |
19,856
-1
| -0% | -$1 | ﹤0.01% | 3284 |
|
|
2021
Q4 | $22K | Hold |
19,857
| – | – | ﹤0.01% | 3233 |
|
|
2021
Q3 | $37K | Sell |
19,857
-6,395
| -24% | -$14.4K | ﹤0.01% | 3206 |
|
|
2021
Q2 | $83K | Sell |
26,252
-2,654
| -9% | -$6.63K | ﹤0.01% | 3163 |
|
|
2021
Q1 | $94K | Buy |
28,906
+4,413
| +18% | +$16K | ﹤0.01% | 3050 |
|
|
2020
Q4 | $15K | Buy |
24,493
+3,549
| +17% | +$1.62K | ﹤0.01% | 2964 |
|
|
2020
Q3 | $7K | Buy |
+20,944
| New | +$8.11K | ﹤0.01% | 2852 |
|
|
2019
Q4 | – | Sell |
-5,241
| Closed | -$42K | – | 2958 |
|
|
2019
Q3 | $42K | Buy |
5,241
+308
| +6% | +$4.19K | ﹤0.01% | 2714 |
|
|
2019
Q2 | $87K | Sell |
4,933
-1,744
| -26% | -$38.2K | ﹤0.01% | 2698 |
|
|
2019
Q1 | $207K | Buy |
6,677
+696
| +12% | +$23.3K | ﹤0.01% | 2484 |
|
|
2018
Q4 | $176K | Buy |
5,981
+1,923
| +47% | +$87.4K | ﹤0.01% | 2300 |
|
|
2018
Q3 | $306K | Buy |
4,058
+150
| +4% | +$10.2K | ﹤0.01% | 2270 |
|
|
2018
Q2 | $222K | Hold |
3,908
| – | – | ﹤0.01% | 2418 |
|
|
2018
Q1 | $86K | Sell |
3,908
-577
| -13% | -$13.2K | ﹤0.01% | 2400 |
|
|
2017
Q4 | $113K | Buy |
+4,485
| New | +$138K | ﹤0.01% | 2368 |
|
|
2017
Q1 | – | Sell |
-1,033
| Closed | -$17K | – | 2534 |
|
|
2016
Q4 | $17K | Buy |
1,033
+77
| +8% | +$1.58K | ﹤0.01% | 2300 |
|
|
2016
Q3 | $21K | Hold |
956
| – | – | ﹤0.01% | 2250 |
|
|
2016
Q2 | $15K | Buy |
+956
| New | +$30K | ﹤0.01% | 2247 |
|
Other funds holding ASXC
Raymond James Financial Services Advisors's ASXC Position: Q3 2024 in Review
Raymond James Financial Services Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 14,072 shares — an estimated $4.69K sold.
Raymond James Financial Services Advisors first reported a position in ASXC in Q2 2016 and held it in 27 quarters. The position peaked at $306K in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.
- Raymond James Financial Services Advisors reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 14,072 Asensus Surgical, Inc. shares in Q3 2024, an estimated $4.69K.
- Raymond James Financial Services Advisors first reported a position in Asensus Surgical, Inc. in Q2 2016 and held it in 27 quarters.
- Raymond James Financial Services Advisors's Asensus Surgical, Inc. position peaked at $306K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.